Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-194P, also known as RNA, U7 small nuclear 194 pseudogene, is a human pseudogene related to the functional U7 small nuclear RNA (U7 snRNA)[7]. The U7 snRNA is an RNA molecule that plays a critical role in the 3' end processing of replication-dependent histone pre-mRNAs as part of the U7 small nuclear ribonucleoprotein (snRNP) complex[1][4][5]. However, RNU7-194P itself is classified as a pseudogene—an inactive copy of the U7-snRNA gene that has accumulated sequence changes and is not known to produce a functional RNA product. Pseudogenes like RNU7-194P typically do not encode proteins or functional RNAs and lack a direct molecular function[7]. While some pseudogenes may have subtle regulatory or non-coding RNA-related roles (such as microRNA sponging or chromatin structure modulation), there is no evidence supporting such a role for RNU7-194P specifically[6][7]. Therefore, RNU7-194P is not considered a therapeutic target, is not known to participate in biological or disease processes, and has no associated drugs, biomarkers, or safety concerns.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 194 pseudogene (RNU7-194P).